Dynavax Technologies | DVAX - Trade Creditors



Dynavax Technologies reported $2.7M in Trade Creditors for its fiscal quarter ending in June of 2025.


Trade Creditors Change Date
AbbVie 2.94B 2.66B Dec/2024
Adma Biologics USD 29.77M 9.55M Jun/2025
Amgen USD 18.03B 15.63B Jun/2025
AstraZeneca 23.99B 1.44B Jun/2025
Biogen USD 408.4M 16.9M Jun/2025
BioMarin Pharmaceutical 684.25M 390.5M Jun/2025
Bristol-Myers Squibb USD 5.43B 1.42B Jun/2025
Dynavax Technologies USD 2.7M 1.63M Jun/2025
Gilead Sciences USD 582M 155M Jun/2025
Glaxosmithkline 13.65B 10.19B Jun/2025
Merck USD 4.04B 261M Jun/2025
Neurocrine Biosciences 104.6M 5.4M Jun/2025
Novartis USD 4.51B 245M Jun/2025
Pfizer USD 5.17B 74M Jun/2025
Regeneron Pharmaceuticals USD 723.9M 18.4M Jun/2025
Roche Holding 4.35B 828M Dec/2024
Sarepta Therapeutics USD 136.7M 19.4M Jun/2025
TG Therapeutics 134.02M 92.06M Jun/2025
Vertex Pharmaceuticals USD 3.71B 3.27B Jun/2025